GLOBAL MARKETS FOR ORTHOBIOLOGIC PRODUCTS FOR THE REPAIR AND REGENERATION OF BONE

101 Pages | 37 Exhibits | 2016 Analysis | Forecasts Through 2020 Product Family: Market Reports




OVERVIEW:
This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global orthobiologic products market for the repair of bone.

ORTHOBIOLOGIC MARKET HIGHLIGHTS

  • Musculoskeletal disorders are the second leading cause of disability in the world. Procedures treating musculoskeletal disorders are expected to continue to rise as the elderly population expands. In addition, the global rise in obesity and the prevalence of sedentary lifestyles will also contribute to an increase in musculoskeletal disorders.
  • Innovation and next-generation therapies are driving product sales. Stem cell-based therapies anticipated to grow at double-digit rates during the forecast period (2015-20).
  • The global market for bone orthobiologics is anticipated to experience healthy growth during the forecast period (2015-20), reaching almost $3bn by 2020.
  • The US currently accounts for 65% of all bone orthobiologic sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK).
  • The largest growth is expected to occur in the RoW region, which includes the Asia-Pacific market. By 2020, the RoW market for orthobiologics for the repair of bone will surpass the five major European markets.
Topics Covered Include:
  • An overview of bone allografts, growth factor-based orthobiologics, and cellular bone matrix products for bone repair.
  • Which products are succeeding and which products are struggling to compete in this highly competitive market?
  • Which competitors are leading the market and introducing new technology?
  • How are country/region-specific factors affecting the market?
  • How are mergers and acquisitions affecting the competitive landscape?


TABLE OF CONTENTS:
EXECUTIVE SUMMARY
 
i. Methodology 

Exhibit ES-1: Global Bone Orthobiologic Products Market, Share by Country/Region, 2015 
Exhibit ES-2: Global Bone Orthobiologics Market, Share by Product Type, 2015 

1. OVERVIEW OF MUSCULOSKELETAL DISEASES/DISORDERS
 
1.1 Back Pain 
1.2 Osteoarthritis 
1.3 Osteoporosis and Fractures 

Exhibit 1-1: Musculoskeletal Surgery, Procedure Volumes Forecast (000s), 2015-20 
Exhibit 1-2: Estimated Prevalence of Osteoarthritis in Adults Aged 45 Years and Older (000s), 2015-20 
Exhibit 1-3: Estimated Prevalence of Osteoporosis, Select Countries 

2. ORTHOBIOLOGICS FOR THE REPAIR AND REGENERATION OF BONE
 
2.1 Bone Graft and Bone Substitute Products 
	2.1.1 Bone Autograft 
	2.1.2 Bone Allografts and Machined Bone 
	2.1.3 Demineralized Bone Matrix 
2.2 Growth Factor-Based Bone Grafts 
2.3 Cellular-based Orthobiologics Currently Available or in Development 
	2.3.1 Cellular Bone Matrices 
	2.3.2 Cellular Regeneration Therapies in Development for Hard Bone Musculoskeletal Repair 

Exhibit 2-1: Selected Bone Allograft and Machined Bone Products, 2015 
Exhibit 2-2: Selected Demineralized Bone Matrix Products, 2015
Exhibit 2-3: Selected Growth-Factor Based Orthobiologic Products Currently Available 
Exhibit 2-4: Selected Growth-Factor Based Products Currently in Development 
Exhibit 2-5: Selected Cellular Bone Matrix Products Currently Available or in Development for Bone Repair 

3. GLOBAL MARKETS FOR GROWTH FACTOR-BASED ORTHOBIOLOGS
 
3.1 Global Competitive Analysis 
3.2 Market Forecast: United States 
	3.2.1 Competitive Analysis 
3.3 Market Forecast: Europe 
	3.3.1 Competitive Analysis 
3.4 Market Forecast: Japan 
	3.4.1 Competitive Analysis 
3.5 Market Forecast: Rest of the World 
	3.5.1 Competitive Analysis 

Exhibit 3-1: Growth Factor-Based Orthobiologic Products, Global Market Forecast, 2015-20 
Exhibit 3-2: Global Growth Factor-Based Orthobiologic Sales by Country/Region, Combined Market Forecast, 2015-20 
Exhibit 3-3: Global Growth Factor-Based Orthobiologic Products Market, Share by Country/Region, 2015 
Exhibit 3-4: Global Growth Factor-Based Orthobiologic Products Market, Share by Supplier, 2015
Exhibit 3-5: United States Growth Factor-Based Orthobiologic Products, Market Forecast, 2015-20 
Exhibit 3-6: United States Growth Factor-Based Products Market, Share by Supplier, 2015 
Exhibit 3-7: Healthcare Statistics for Select European Countries, 2013 
Exhibit 3-8: European Growth Factor-Based Orthobiologic Products, Market Forecast, 2015-20 
Exhibit 3-9: European Growth Factor-Based Orthobiologic Products Market, Share by Supplier, 2015 
Exhibit 3-10: Japanese Growth Factor-Based Orthobiologic Products, Market Forecast, 2015-20 
Exhibit 3-11: Japanese Growth Factor-Based Orthobiologic Products Market, Share by Supplier, 2015 
Exhibit 3-12: Rest of the World Growth Factor-Based Orthobiologic Products, Market Forecast, 2015-20 
Exhibit 3-13: Rest of the World Growth Factor-Based Orthobiologic Products Market, Share by Supplier, 2015 

4. GLOBAL MARKETS FOR BONE ALLOGRAFTS
 
4.1 Global Competitive Analysis 
4.2 Market Forecast: United States 
4.3 Market Forecast: Europe 
4.4 Market Forecast: Japan 
4.5 Market Forecast: Rest of the World 

Exhibit 4-1: Bone Graft and Graft Substitute Products, Global Market Forecast, 2015-20 
Exhibit 4-2: Global Bone Allograft Product Sales by Country/Region, Combined Market Forecast, 2015-20
Exhibit 4-3: Global Bone Allograft Products Market, Share by Country/Region, 2015 
Exhibit 4-4: Global Bone Allografts Market, Share by Supplier, 2015 
Exhibit 4-5: United States Bone Allograft Products, Market Forecast, 2015-20 
Exhibit 4-6: European Bone Allograft Products, Market Forecast, 2015-20 
Exhibit 4-7: Japanese Bone Allograft Products, Market Forecast, 2015-20 
Exhibit 4-8: Rest of the World Bone Allograft Products, Market Forecast, 2015-20 

5. GLOBAL MARKETS FOR STEM CELL GRAFTS
 
5.1 Global Competitive Analysis 
5.2 Market Forecast: US 
5.3 Market Forecast: Rest of the World 

Exhibit 5-1: Cellular Bone Matrices, Global Market Forecast, 2015-20 
Exhibit 5-2: Global Cellular Bone Matrix Product Sales by Country/Region, Combined Market Forecast, 2015-20 
Exhibit 5-3: Global Cellular Bone Matrix Products Market, Share by Country/Region, 2015 
Exhibit 5-4: Global Cellular Bone Matrix Products Market, Share by Supplier, 2015
Exhibit 5-5: US Cellular Bone Matrix Products, Market Forecast, 2015-20 
Exhibit 5-6: Rest of the World Cellular Bone Matrix Products, Market Forecast, 2015-20 

APPENDIX: COMPANY LISTING 

BIBLIOGRAPHY 


COMPANIES COVERED:

  1. Aesculap Implant Systems
  2. AlloSource
  3. Alphatec Spine
  4. Arthrex
  5. B. Braun Melsungen AG
  6. Bacterin International
  7. Bioventus
  8. Cerapedics
  9. Collagen Matrix
  10. DePuy Synthes/ Johnson & Johnson
  11. Ember Therapeutics
  12. Exactech
  13. Ferring Pharmaceuticals
  14. Globus Medical
  15. Integra LifeSciences
  16. ISTO Technologies
  17. Johnson & Johnson
  18. K2M
  19. LifeNet Health
  20. Medtronic
  21. Musculoskeletal Transplant Foundation
  22. NuVasive
  23. Orthofix
  24. Osiris Therapeutics
  25. RTI Surgical
  26. Stryker
  27. Wright Medical Group
  28. Zimmer Biomet
Contact Us

Need help finding medtech research? Let us help you!